Serum interleukin-22 levels in monitoring the effect of treatment with dual bronchodilation in patients with COPD: should it be considered? - Vienna 2024

Chronic obstructive pulmonary disease biomarkers: feasible options for clinicians?

Chair(s): Maeva Zysman, Ian M. Adcock

Session type: Poster session

Serum interleukin-22 levels in monitoring the effect of treatment with dual bronchodilation in patients with COPD: should it be considered?

Ieva Dimiene

EVENTS HOME

Poster
Abstract

Previous presentation

Next presentation

Session content

Serum interleukin-22 levels in monitoring the effect of treatment with dual bronchodilation in patients with COPD: should it be considered?

Ieva Dimiene

Poster

Abstract

The utility of using FeNO with blood eosinophil counts (BEC) in identifying inflammatory endotypes in stable state COPD.

Arun Prasad

Poster

Abstract

Mucus Plug Lobar Distribution in COPD Using Automatic AI-Based Mucus Plug Quantification

Tjeerd Van Der Veer

Poster

Abstract

Systemic Leukotriene Levels in COPD: Insights into Disease Pathogenesis and Severity

Warda Jelassi

Poster

Abstract

The relationship between airway thickness and persistent eosinophilia in COPD

Federico Baraldi

Poster

Abstract

Association between FeNO, blood eosinophil counts (BEC) and exacerbation frequency in ICS treatment groups in COPD.

Arun Prasad

Poster

Abstract

VO2 peak as a predictor of COPD severity

Andreia Casimiro Daniel

Poster

Abstract

Within-day variability of Fractional exhaled Nitric Oxide in stable COPD patients.

Eef Vanderhelst

Poster

Abstract

Airway microbiota as a biomarker in predicting COPD and control

Solveig Tangedal

Poster

Abstract

Transfer coefficient and static hyperinflation as markers of COPD disease activity: Results from COSYCONET

Hendrik Pott

Poster

Abstract

Midregional pro atrial naturetic peptide (MRproANP) is a predictor of all-cause mortality in mild to moderate COPD - an analysis of COSYCONET data

Sebastian F?hndrich

Poster

Abstract

Homocysteine as a multifunctional indicator of thrombophilia, endothelial dysfunction and systemic inflammation in patients with COPD

Elnorahon Abduganieva

Poster

Abstract

Serum markers of bone metabolism correlate with clinical parameters for disease progression during 2 years follow-up in patients with COPD

Dimo Dimov

Poster

Abstract

High-Risk Asian COPD characterized by mucus-metabolic-microbial dysbiosis

Oliver Ward Meldrum

Poster

Abstract

Association of serum surfactant protein-D levels with COPD severity and clinical history.

Hemant Kumar

Poster

Abstract

Distribution of type-2 biomarkers and association with disease traits in patients with COPD, Data from the BREATHE Cohort

Sigrid Brisson Nielsen

Poster

Abstract

DETECTION AND CHARACTERIZATION OF EXTRACELLULAR VESICLES IN SPUTUM OF COPD PATIENTS AND HEALTHY CONTROL

Ourania Kotsiou

Poster

Abstract

Validation of exhaled volatile organic compounds as biomarkers for COPD exacerbations

Jorrit Van Poelgeest

Poster

Abstract

Zinc content in biological media in patients with COPD

Alla Zuban

Poster

Abstract

Resolvins as Biomarkers in Chronic Obstructive Pulmonary Disease: Assessing Disease Severity

Warda Jelassi

Poster

Abstract

CDN Connection Issue

The ERS Congress 2024, Vienna

#{title}